| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
National Dentex Corporation is a network of local dental labratories providing the competitive pricing and resources of a large laboratory along with the personalized support of a local lab. NDX has more than 40 locations across the United States and Canada.
Sansum Medical Research Institute is a Santa Barbara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ADM Benefit Plans Agency is a Bucyrus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Saint Lukes Health System is a non-profit hospital network in the bi-state Kansas City metro area, located in northeast Kansas and northwest Missouri.